Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating adding stereotactic body radiation therapy to standard drug therapy for breast cancer, including oligometastatic and meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Oligometastatic Breast Carcinoma, Breast Cancer | Phase 2 | Status: RECRUITING